Prevalence and Risk Factors of Significant Hepatic Fibrosis in Omani Patients with HBeAg-negative Chronic Hepatitis B Virus Infection: A Retrospective Study
- PMID: 40212575
- PMCID: PMC11980033
- DOI: 10.5001/omj.2024.113
Prevalence and Risk Factors of Significant Hepatic Fibrosis in Omani Patients with HBeAg-negative Chronic Hepatitis B Virus Infection: A Retrospective Study
Abstract
Objectives: Hepatic fibrosis remains a potential complication for hepatitis B e antigen (HBeAg)-negative chronic hepatitis B virus (HBV) infection. The affected individuals, known as inactive HBV carriers, tend to have a favorable prognosis. This study aimed to determine the prevalence of significant fibrosis and associated risk factors among Omani patients diagnosed as inactive HBV carriers.
Methods: A retrospective study was conducted on Omani inactive HBV carriers visiting a tertiary hospital in Muscat, Oman, between January 2017 and December 2018. Significant hepatic fibrosis (stage F2 or higher) was identified using two-dimensional shear-wave elastography, with baseline clinical, laboratory, and radiological data analyzed for associations.
Results: Among the selected 200 participants (mean age = 44.6 ± 9.3 years), 53.0% were male. Significant fibrosis was present in 40 (20.0%) patients, with a preponderance of male (p =0.007) and those aged ≥ 60 years (p =0.024). Fatty changes, as detected by liver ultrasound, were independent risk factors (p =0.044).
Conclusions: The findings underscore the importance of periodic assessment and monitoring of inactive HBV carriers in Oman, particularly those with risk factors for fibrosis progression, such as male sex, older age, and fatty liver. Non-invasive tests can aid in early detection and management of fibrosis, thereby improving patient outcomes.
Keywords: Hepatic Fibrosis; Inactive Hepatitis B Virus Carriers; Oman; Prevalence; Risk Factors.
Copyright © 2024, Oman Medical Journal.
Figures
Similar articles
-
A Comprehensive Analysis of Inactive Hepatitis B Infection in a Cohort of Omani Patients.Oman Med J. 2024 Sep 30;39(5):e673. doi: 10.5001/omj.2024.104. eCollection 2024 Sep. Oman Med J. 2024. PMID: 40060980 Free PMC article.
-
Liver histopathological lesions is severe in patients with normal alanine transaminase and low to moderate hepatitis B virus DNA replication.World J Gastroenterol. 2023 Apr 28;29(16):2479-2494. doi: 10.3748/wjg.v29.i16.2479. World J Gastroenterol. 2023. PMID: 37179582 Free PMC article.
-
[Clinical value of noninvasive method in diagnosing hepatic fibrosis about chronic HBV carriers].Zhonghua Gan Zang Bing Za Zhi. 2018 May 20;26(5):332-336. doi: 10.3760/cma.j.issn.1007-3418.2018.05.004. Zhonghua Gan Zang Bing Za Zhi. 2018. PMID: 29996199 Chinese.
-
Chronic hepatitis B virus infection in Asian countries.J Gastroenterol Hepatol. 2000 Dec;15(12):1356-61. doi: 10.1046/j.1440-1746.2000.0150121356.x. J Gastroenterol Hepatol. 2000. PMID: 11197043 Review.
-
The prognosis and management of inactive HBV carriers.Liver Int. 2016 Jan;36 Suppl 1:100-4. doi: 10.1111/liv.13006. Liver Int. 2016. PMID: 26725905 Review.
References
LinkOut - more resources
Full Text Sources
Miscellaneous